Related Experiment Video

Updated: Jan 18, 2026

Live-Cell Forward Genetic Approach to Identify and Isolate Developmental Mutants in Chlamydia trachomatis
10:32

Live-Cell Forward Genetic Approach to Identify and Isolate Developmental Mutants in Chlamydia trachomatis

Published on: June 10, 2020

4.5K

Rifampin in chlamydial infections

J Schachter

    Reviews of Infectious Diseases
    |July 1, 1983
    PubMed

    Insights

    Rifampin is a potent antibiotic against Chlamydia trachomatis. Despite concerns about resistance, clinical trials show it is as effective as tetracyclines for treating chlamydial infections and trachoma.

    Area of Science:

    • Microbiology
    • Infectious Diseases
    • Ophthalmology

    Background:

    • Chlamydia trachomatis is a common bacterial pathogen causing various infections.
    • Rifampin exhibits high in vitro activity against Chlamydia trachomatis on a weight basis.
    • Concerns regarding the rapid emergence of rifampin resistance in vitro have limited clinical investigations.

    Purpose of the Study:

    • To evaluate the efficacy of rifampin in treating human chlamydial infections.
    • To compare the effectiveness of rifampin with established treatments like tetracyclines.

    Main Methods:

    • Review of existing clinical trials investigating rifampin for chlamydial infections.
    • Analysis of treatment outcomes for C. trachomatis urethral infections and trachoma.

    Main Results:

    • Rifampin demonstrated significant effectiveness against Chlamydia trachomatis.
    • Clinical studies indicated rifampin is comparable in efficacy to tetracyclines.
    • Successful treatment outcomes were observed for male urethral infections and topical trachoma treatment.

    Conclusions:

    • Rifampin is a viable and effective treatment option for Chlamydia trachomatis infections.
    • Despite in vitro resistance concerns, rifampin shows clinical efficacy comparable to tetracyclines.
    • Further research may be warranted to explore rifampin's role in treating chlamydial diseases.

    More Related Videos

    Using Fluorescent Proteins to Visualize and Quantitate Chlamydia Vacuole Growth Dynamics in Living Cells07:42

    Using Fluorescent Proteins to Visualize and Quantitate Chlamydia Vacuole Growth Dynamics in Living Cells

    Published on: October 13, 2015

    7.9K
    Forward Genetic Approaches in Chlamydia trachomatis09:03

    Forward Genetic Approaches in Chlamydia trachomatis

    Published on: October 23, 2013

    13.3K

    Related Concept Videos

    Acute Pyelonephritis II: Diagnostic Studies and Management01:28

    Acute Pyelonephritis II: Diagnostic Studies and Management

    Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
    323
    Bacterial Phylum Chlamydiae01:29

    Bacterial Phylum Chlamydiae

    The phylum Chlamydiae or Chlamydiota is composed of a single order, Chlamydiales. This phylum consists entirely of obligate intracellular parasites that infect eukaryotic hosts. While human pathogens within this group have been studied extensively, the phylum encompasses many species capable of interacting with various eukaryotic organisms. Members of Chlamydiae are typically small cocci, approximately 0.5 μm in diameter, and exhibit a distinctive developmental cycle. As is characteristic...
    430
    Rheumatic Heart Disease III: Medical Management01:21

    Rheumatic Heart Disease III: Medical Management

    Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
    290
    Pulmonary Tuberculosis V01:28

    Pulmonary Tuberculosis V

    Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
    Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
    543
    Acute Pharyngitis01:30

    Acute Pharyngitis

    Introduction
    Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
    Classification
    Acute pharyngitis can be categorized based on its underlying cause:
    3.9K
    Sexually Transmitted Infections01:26

    Sexually Transmitted Infections

    Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
    941